Product quality & regulation

The label problem, and the legal reality

CJC-1295 carries a labelling problem most peptides do not. FDA counts five distinct substances under this one name, across two different active moieties, and at least nine names used for them over the years. It calls that confusion a safety risk in its own right: a patient may be dosed with a different substance than the physician ordered. On top of that, CJC-1295 is not an approved medicine in the US or in any of the other countries FDA checked, and it is banned in sport.

This unit covers the two things a careful reader most needs: how to think about product identity and quality in an unregulated market, and exactly where CJC-1295 stands legally with the FDA and the anti-doping system. Both are about protecting yourself from confident claims that do not hold up.